Ilika (IKA) H1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2026 earnings summary
22 Jan, 2026Executive summary
Achieved key milestones in Stereax (miniature solid-state batteries for medical/IoT) and Goliath (large-format batteries for automotive and consumer appliances), including Stereax commercial deliveries and Goliath 10Ah prototype shipments.
Asset-light, IP-driven business model with Stereax licensed to Cirtec Medical and Goliath at prototype stage; Stereax manufacturing qualified at Cirtec's US facility.
Stereax integration with Cirtec's power management platform and initial application designs expected in 2026.
Goliath: customer feedback on 10Ah prototypes pending, with licensing discussions and plans to refine prototypes for MVP A-Sample in 2026.
Secured first revenue-generating purchase order for Stereax electrodes and expanded evaluation agreements pipeline to 27 companies.
Financial highlights
Turnover/revenue for the half-year: £0.6 million, down year-over-year due to timing of grant funding.
EBITDA loss increased to £3.2m, reflecting lower turnover and higher material costs for Goliath prototype ramp-up.
Operating loss for the period was £4.5m, compared to £3.1m in the prior year.
Cash and cash equivalents at period end: £6.9 million, with additional R&D tax credit received post-period.
Successful gross fundraising of £4.2m to support product roadmaps and commercialisation.
Outlook and guidance
Stereax: commercial revenues starting from cathode deliveries, with product sales expected before end of 2026 and plans to ramp sales as regulatory approvals progress.
Goliath: licensing window open, with discussions expected to continue over the next 30 months; plans to refine 10Ah prototypes and move towards MVP A-Sample in 2026.
Intends to broaden Goliath's customer base, targeting consumer appliance and defence sectors in addition to automotive OEMs and Tier 1 suppliers.
Key 2026 milestones: Stereax integration into Cirtec development board, Goliath customer feedback and MVP definition.
Confident in securing larger follow-on orders for Stereax M300 batteries from the current customer base.
Latest events from Ilika
- Battery tech milestones, revenue up 200%, and commercialisation accelerates.IKA
H2 202420 Feb 2026 - Stereax and Goliath batteries progress toward commercialization, with first Stereax revenues due in 2025.IKA
H1 202510 Jan 2026 - Up to £3.8m raised to accelerate Stereax and Goliath battery commercialization and licensing.IKA
Investor Update26 Nov 2025 - Revenue declined as grants ended, but Stereax and Goliath progress and cash reserves remain strong.IKA
H2 202516 Nov 2025 - Asset-light solid-state battery strategy targets medical and automotive markets with validated technology.IKA
CMD 2025 Presentation17 Jul 2025 - Stereax and Goliath battery projects progress, with 2025 production and key milestones achieved.IKA
Trading Update13 Jun 2025